NSPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
InspireMD Inc (NSPR) is not a strong buy at the moment for a beginner investor with a long-term focus. Despite positive financial growth trends and a favorable analyst rating, the lack of significant trading signals, neutral technical indicators, and absence of recent news or catalysts suggest a hold position. The stock's pre-market price of $1.73 is below the pivot support level, and the short-term trend does not indicate strong upward momentum.
The MACD is positive but contracting, RSI is neutral at 47.79, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot level of $1.78, with key support at $1.643 and resistance at $1.918.
Revenue increased by 61.57% YoY in Q4 2025, and gross margin improved significantly by 55.74% YoY. Analyst rating from Maxim indicates a Buy with a $6 price target.
No recent news or event-driven catalysts. Stock trend analysis shows limited short-term upside potential with a 50% chance of a 2.31% increase in the next day but a potential -3.65% decline in the next month.
In Q4 2025, revenue grew to $3,149,000 (up 61.57% YoY), net income improved to -$11,761,000 (up 28.20% YoY), and gross margin increased to 37.47% (up 55.74% YoY). However, EPS dropped to -0.14 (down -26.32% YoY).
Maxim initiated coverage with a Buy rating and a $6 price target on 2026-02-02.
